JP4718099B2 - ストレプトコッカス・パイオジェンス抗原 - Google Patents

ストレプトコッカス・パイオジェンス抗原 Download PDF

Info

Publication number
JP4718099B2
JP4718099B2 JP2002509358A JP2002509358A JP4718099B2 JP 4718099 B2 JP4718099 B2 JP 4718099B2 JP 2002509358 A JP2002509358 A JP 2002509358A JP 2002509358 A JP2002509358 A JP 2002509358A JP 4718099 B2 JP4718099 B2 JP 4718099B2
Authority
JP
Japan
Prior art keywords
polypeptide
seq
polynucleotide
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2002509358A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004502446A5 (enExample
JP2004502446A (ja
Inventor
マーティン，デニス
ハメル，ジョゼ
ブロドゥール，ベルナール
リウー，ステファン
ボイアー，マルティーヌ
Original Assignee
アイディー バイオメディカル コーポレイション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アイディー バイオメディカル コーポレイション filed Critical アイディー バイオメディカル コーポレイション
Publication of JP2004502446A publication Critical patent/JP2004502446A/ja
Publication of JP2004502446A5 publication Critical patent/JP2004502446A5/ja
Application granted granted Critical
Publication of JP4718099B2 publication Critical patent/JP4718099B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2002509358A 2000-07-06 2001-07-06 ストレプトコッカス・パイオジェンス抗原 Expired - Fee Related JP4718099B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21646500P 2000-07-06 2000-07-06
US60/216,465 2000-07-06
PCT/CA2001/001001 WO2002004495A2 (en) 2000-07-06 2001-07-06 Streptococcus pyogenes antigen

Publications (3)

Publication Number Publication Date
JP2004502446A JP2004502446A (ja) 2004-01-29
JP2004502446A5 JP2004502446A5 (enExample) 2008-09-04
JP4718099B2 true JP4718099B2 (ja) 2011-07-06

Family

ID=22807177

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002509358A Expired - Fee Related JP4718099B2 (ja) 2000-07-06 2001-07-06 ストレプトコッカス・パイオジェンス抗原

Country Status (10)

Country Link
US (2) US7247308B2 (enExample)
EP (1) EP1297145B1 (enExample)
JP (1) JP4718099B2 (enExample)
AT (1) ATE412750T1 (enExample)
AU (1) AU7227001A (enExample)
BR (1) BR0112497A (enExample)
CA (1) CA2413576C (enExample)
DE (1) DE60136360D1 (enExample)
ES (1) ES2316458T3 (enExample)
WO (1) WO2002004495A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7227001A (en) 2000-07-06 2002-01-21 Shire Biochem Inc Streptococcus pyogenes antigens
WO2002034771A2 (en) 2000-10-27 2002-05-02 Chiron Srl Nucleic acids and proteins from streptococcus groups a & b
AU1686302A (en) * 2000-12-21 2002-07-01 Shire Biochem Inc Streptococcus pyogenes antigens and corresponding dna fragments
WO2004018646A2 (en) * 2002-08-26 2004-03-04 Chiron Corporation Conserved and specific streptococcal genomes
EP1648500B1 (en) 2003-07-31 2014-07-09 Novartis Vaccines and Diagnostics, Inc. Immunogenic compositions for streptococcus pyogenes
WO2005017093A2 (en) * 2003-08-15 2005-02-24 Id Biomedical Corporation Polypeptides of streptococcus pyogenes
US8945589B2 (en) * 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
EP1784211A4 (en) 2004-07-29 2010-06-30 Novartis Vaccines & Diagnostic IMMUNOGENIC COMPOSITIONS FOR GRAMPOSITIVE BACTERIA SUCH AS STREPTOCOCCUS AGALACTIAE
AU2005294275B2 (en) * 2004-10-08 2012-09-13 Glaxosmithkline Biologicals S.A. Immunogenic and therapeutic compositions for Streptococcus pyogenes
GB2428006A (en) * 2005-07-07 2007-01-17 Jevgenis Morov AMI-3 vaccine comprising group A Streptococcus pyogenes bacteria
WO2008020335A2 (en) * 2006-06-09 2008-02-21 Novartis Ag Immunogenic compositions for streptococcus agalactiae
AU2007348285A1 (en) * 2006-10-30 2008-09-12 Novartis Ag Immunogenic and therapeutic compositions for streptococcus pyogenes
AU2008299376B2 (en) 2007-09-12 2013-02-28 Glaxosmithkline Biologicals S.A. GAS57 mutant antigens and GAS57 antibodies
NZ586430A (en) 2007-12-21 2012-09-28 Novartis Ag Mutant forms of streptolysin o (slo)
AU2012271336B2 (en) 2011-06-17 2017-03-02 University Of Tennessee Research Foundation Group A streptococcus multivalent vaccine
AU2014214613A1 (en) 2013-02-11 2015-08-13 University Of Tennessee Research Foundation Group A streptococcal M-related proteins and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0916726A1 (en) * 1997-11-13 1999-05-19 Rijksuniversiteit te Groningen Attaching substances to micro-organisms
AU7227001A (en) * 2000-07-06 2002-01-21 Shire Biochem Inc Streptococcus pyogenes antigens

Also Published As

Publication number Publication date
CA2413576C (en) 2012-11-13
US7247308B2 (en) 2007-07-24
US7811585B2 (en) 2010-10-12
US20080038268A1 (en) 2008-02-14
WO2002004495A2 (en) 2002-01-17
BR0112497A (pt) 2003-11-25
EP1297145A2 (en) 2003-04-02
DE60136360D1 (de) 2008-12-11
JP2004502446A (ja) 2004-01-29
ES2316458T3 (es) 2009-04-16
US20030165528A1 (en) 2003-09-04
WO2002004495A3 (en) 2002-06-13
ATE412750T1 (de) 2008-11-15
AU7227001A (en) 2002-01-21
CA2413576A1 (en) 2002-01-17
EP1297145B1 (en) 2008-10-29

Similar Documents

Publication Publication Date Title
US7811585B2 (en) Streptococcus pyogenes antigens
JP5039802B2 (ja) 新規連鎖球菌抗原
JP5889103B2 (ja) ストレプトコッカス抗原
AU2001270381A1 (en) Streptococcus antigens
WO2003054007A2 (en) Streptococcus antigens
US20160326221A1 (en) Streptococcus pyogenes antigens and corresponding dna fragments
US7074415B2 (en) Streptococcus antigens
JP4281861B2 (ja) Ｓｔｒｅｐｔｏｃｏｃｃｕｓ ｐｙｏｇｅｎｅｓポリペプチドおよび対応するｄｎａフラグメント
AU2002234455A1 (en) Streptococcus pyogenes polypeptides and corresponding DNA fragments
JP2005501534A (ja) グループｂ連鎖球菌の抗原及び対応するｄｎａ断片
AU2001272270B2 (en) Streptococcus pyogenes antigen
AU2001272270A1 (en) Streptococcus pyogenes antigen
WO2002079475A2 (en) Streptococcus pyogenes antigens and corresponding dna fragments

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20070829

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080707

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080707

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110301

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110331

R150 Certificate of patent or registration of utility model

Ref document number: 4718099

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140408

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees